NGEN

NERVGEN PHARMA CORP

NGEN·64082X203·US·Common Stock·Healthcare - Biotechnology

NGEN (NERVGEN PHARMA CORP) is held by 36 institutional investors as of Q2 2026. Largest holders: LMR Partners LLP ($1.2M), MARSHALL WACE, LLP ($898,081), UBS Group AG ($782,236). Net institutional sentiment: Bullish.

36
Holders
(7 Elite)
$6.5M
Total Value
81% (31)
Consensus
25 buying - 6 selling
13F: Insider & Congress: Updated regularly
NGEN

Smart Money Verdict

View all
Loading verdict
Held by 36 funds
7 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for NGEN.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
600,000$1.2M0.0%+7.28%
35
Increased
435,962(+117.6%)$898,0810.0%-24.54%
40
Increased
379,726(+517.3%)$782,2360.0%-6.60%
40
New
270,750$557,7460.0%+7.28%
37
New
250,500$516,0300.0%+7.28%
33
Decreased
186,200(-7.2%)$383,5720.0%-44.05%
0
Increased
176,075(+2.4%)$363,0000.0%-43.42%
24
Increased
78,394(+24.6%)$284,3820.0%-38.21%
29
New
134,518$277,1070.0%+7.28%
32
Decreased
74,215(-14.5%)$152,8830.0%-44.05%
0
Increased
64,423(+3.3%)$132,7110.0%-43.18%
23
New
58,040$119,5620.0%+7.28%
34
Increased
51,093(+27.8%)$105,2500.0%-37.56%
27
New
39,740$81,8640.0%+7.28%
33
Decreased
33,000(-1.1%)$67,9800.0%-44.05%
0
Unchanged
31,400$64,6840.0%-44.05%
0
Increased
26,710(+99.3%)$55,0230.0%-26.53%
23
Unchanged
23,800$49,8120.0%-44.05%
0
New
22,000$45,3200.0%+7.28%
31
Unchanged
20,000$41,2000.0%-44.05%
0

Showing 1-20 of 38

1 / 2
NGENNGENNERVGEN PHARMA CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used